Are Th2 helper T lymphocytes beneficial, deleterious, or irrelevant in promoting allograft survival?

Transplantation

Volumn 63, Issue 5, 1997, Pages 619-624

  Piccotti, Joseph R ^a   Chan, Sherri Y ^a   VanBuskirk, Anne M ^b   Eichwald, Ernst J ^c   Bishop, D Keith ^a,d  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANTIBODY DEPENDENT CELLULAR CYTOTOXICITY; CYTOTOXIC T LYMPHOCYTE; DELAYED HYPERSENSITIVITY; EFFECTOR CELL; GENE EXPRESSION; GRAFT REJECTION; GRAFT SURVIVAL; HELPER CELL; HUMAN; IMMUNOLOGICAL TOLERANCE; NONHUMAN; PRIORITY JOURNAL; REVIEW; T LYMPHOCYTE SUBPOPULATION;

EID: 0030951832     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199703150-00001     Document Type: Review

References (50)

1. Mosmann TR, Sad S. The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol. Today 1996; 17: 138.
2. Hall B. Cells mediating allograft rejection. Transplantation 1991; 51: 1141.
3. Gajewski TF, Joyce J, Fitch FW. Antiproliferative effect of IFNγ in immune regulation: III. Differential selection of Th1 and Th2 murine helper T lymphocyte clones using recombinant IL-2 and recombinant IFNγ. J Immunol 1989; 143: 15.
4. Swain SL, Weinberg AD, English M, Huston G. IL-4 directs the development of Th2-like helper effectors. J Immunol 1990; 145: 3796.
5. Finkelman FD, Katona IM, Mosmann TR, Coffman RL. IFNγ regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988; 140: 1022.
6. Finkelman FD, Katona IM, Urban JF, Snapper CM, Ohara J, Paul WE. Suppression of in vivo polyclonal IgE responses by monoclonal antibody to the lymphokine B-cell stimulatory factor 1. Proc Natl Acad Sci USA 1986; 83: 9675.
7. Trinchieri G. Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity. Annu Rev Immunol 1995; 13: 251.
8. Sypek JP, Chung CL, Mayor SEH, et al. Resolution of cutaneous leishmaniasis: interleukin 12 initiates a protective T helper type 1 immune response. J Exp Med 1993; 177: 1797.
9. McKnight AJ, Zimmer GJ, Fogelman I, Wolf SF, Abbas AK. Effects of IL-12 on helper T cell-dependent immune responses in vivo. J Immunol 1994; 152: 2172.
10. Marshall JD, Secrist H, DeKruyff RH, Wolf SF, Umetsu DT. IL-12 inhibits the production of IL-4 and IL-10 in allergen-specific human CD4+ T lymphocytes. J Immunol 1995; 155: 111.
11. Ben-Sasson SZ, Le Gros G, Conrad DH, Finkelman FD, Paul WE. Cross-linking Fc receptors stimulate splenic non-B, non-T cells to secrete interleukin 4 and other lymphokines. Proc Natl Acad Sci USA 1990; 87: 1421.
12. pos T cells promptly produce interleukin 4 in response to in vivo challenge with anti-CD3. J Exp Med 1994; 179: 1285.
13. Martinez OM, Gibbons RS, Garovoy MR, Aronson FR. IL-4 inhibits IL-2 receptor expression and IL-2-dependent proliferation of human T cells. J Immunol 1990; 144: 2211.
14. Moore KW, O'Garra A, de Waal Malefyt R, Vieira P, Mosmann TR. Interleukin-10. Annu Rev Immunol 1993; 11: 165.
15. Ding L, Linsley PS, Huang L-Y, Germain RN, Shevach EM. IL-10 inhibits macrophage costimulatory activity by selectively inhibiting the up-regulation of B7 expression. J Immunol 1993; 151: 1224.
16. Sayegh MH, Akalin E, Hancock WW, et al. CD28-B7 blockade after alloantigenic challenge in vivo inhibits Th1 cytokines but spares Th2. J Exp Med 1995; 181: 1869.
17. Bishop DK, Ferguson RM, Orosz CG. Differential distribution of antigen specific helper T cells and cytotoxic T cells following antigenic stimulation in vivo: a functional study using limiting dilution analysis. J Immunol 1990; 144: 1153.
18. Dallman MJ, Shiho O, Page TH, Wood KJ, Morris PJ. Peripheral tolerance to alloantigen results from altered regulation of the interleukin 2 pathway. J Exp Med 1991; 173: 79.
19. O'Connell PJ, Pacheco-Silva A, Nickerson PW, et al. Unmodified pancreatic islet allograft rejection results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093.
20. Pavlakis M, Strehlau J, Lipman M, Shapiro M, Maslinski W, Strom TB. Intragraft IL-15 transcripts are increased in human renal allograft rejection. Transplantation 1996; 62: 543.
21. Krams SM, Falco DA, Villanueva JC, et al. Cytokine and T cell receptor gene expression at the site of allograft rejection. Transplantation 1992; 53: 151.
22. Martinez OM, Villanueva JC, Lake J, Roberts JP, Ascher NL, Krams SM. IL-2 and IL-5 gene expression in response to alloantigen in liver allograft recipients and in vitro. Transplantation 1993; 55: 1159.
23. Thai NL, Fu F, Qian S, et al. Cytokine mRNA profiles in mouse orthotopic liver transplantation: graft rejection is associated with augmented Th1 function. Transplantation 1995; 59: 274.
24. Dallman MJ, Larsen CP, Morris PJ. Cytokine gene transcription in vascularized organ grafts: analysis using semiquantitative polymerase chain reaction. J Exp Med 1991; 174: 493.
25. Morgan CJ, Pelletier RP, Hernandez CJ, et al. Alloantigen-dependent endothelial phenotype and lymphokine mRNA expression in rejecting murine cardiac allografts. Transplantation 1993; 55: 919.
26. + T cells results in Th2 cytokine production and alternate mechanisms of allograft rejection. Transplantation 1995; 59: 1155.
27. Piccotti JR, Chan SY, Goodman RE, Magram J, Eichwald EJ, Bishop DK. IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection: evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J Immunol 1996; 157: 1951.
28. Mohler KM, Streilein JW. Lymphokine production by MLR-reactive reaction lymphocytes obtained from normal mice and mice rendered tolerant of class II MHC antigens. Transplantation 1989; 47: 625.
29. Powell TJ, Streilein JW. Neonatal tolerance by class II alloantigens activates IL-4-secreting, tolerogen-responsive T cells. J Immunol 1990; 144: 854.
30. Donckier V, Martin M, Bruyns C, et al. Critical role of interleukin 4 in the induction of neonatal transplantation tolerance. Transplantation 1995; 59: 1571.
31. Gao Q, Chen N, Field EH. CD4 Th2 cells do not functionally suppress CTL generation in neonatal tolerant mice. Transplantation 1995; 60: 1260.
32. Takeuchi T, Lowry RP, Konieczny B. Heart grafts in murine systems: the differential activation of Th2-like effectors in peripheral tolerance. Transplantation 1992; 53: 1281.
33. Gorczynski RM, Wojcik D. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion. J Immunol 1994; 152: 2011.
34. Mottram PL, Han W-R, Purcell LJ, Mckenzie IFC, Hancock WW. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-γ in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy. Transplantation 1995; 59: 559.
35. Gajewski TF, Scheel SR, Titch FW. Evidence implicating utilization of different T cell receptor-associated signaling pathways by Th1 and Th2 clones. J Immunol 1990; 144: 4110.
36. Ramirez F, Fowell DJ, Puklavec M, Simmonds S, Mason D. Glucocorticoids promote a Th2 cytokine response by CD4+ T cells in vitro. J Immunol 1996; 156: 2406.
37. Larsen CP, Elwood ET, Alexander DZ, et al. Long-term acceptance of skin and cardiac allografts after blocking CD40 and CD28 pathways. Nature 1996; 381: 434.
38. Strom TB, Roy-Chaudhury P, Manfro R, et al. The Th1/Th2 paradigm and the allograft response. Curr Opin Immunol 1996; 8: 688.
39. Lang T, Krams SM, Martinez OM. Production of IL-4 and IL-10 does not lead to immune quiescence in vascularized human organ grafts. Transplantation 1996; 62: 776.
40. Chen N, Gao Q, Field EH. Prevention of Th1 responses is critical for tolerance. Transplantation 1996; 61: 1076.
41. Qian S, Li W, Li Y, et al. Systemic administration of cellular interleukin-10 can exacerbate cardiac allograft rejection in mice. Transplantation 1996; 62: 1709.
42. Zheng XX, Steele AW, Nickerson PW, Steurer W, Steiger J, Strom TB. Administration of noncytolytic IL-10/Fc in murine models of lipopolysaccharide-induced septic shock and allogeneic islet transplantation. J Immunol 1995; 154: 5590.
43. Qin L, Chavin KD, Ding Y, et al. Retrovirus-mediated transfer of viral IL-10 gene prolongs murine cardiac allograft survival. J Immunol 1996; 156: 2316.
44. Martinez OM, Ascher NL, Ferrell L, et al. Evidence for a non-classical pathway of graft rejection involving interleukin 5 and eosinophils. Transplantation 1993; 55: 909.
45. Spry CJF, Kay AB, Gleich GJ. Eosinophils 1992. Immunol Today 1992; 13: 384.
46. Tepper RI, Coffman RL, Leder P. An eosinophil-dependent mechanism for the antitumor effect of interleukin-4. Science 1992; 257: 548.
47. Piccotti JR, Chan SY, Li K, Eichwald EJ, Bishop DK. Differential effects of IL-12 receptor blockade with IL-12 p40 homodimer on the induction of CD4+ and CD8+ IFNγ producing cells. J Immunol 1997; 158: 643.
48. VanBuskirk AM, Wakely ME, Orosz CG. Transfusion of polarized Th2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 1996; 63: 229.
49. Gillessen S, Carvajal D, Ling P, et al. Mouse interleukin-12 (IL-12) p40 homodimer: a potent IL-12 antagonist. Eur J Immunol 1995; 25: 200.
50. Presky DH, Yang H, Minetti LJ, et al. A functional interleukin-12 receptor complex is composed of two β type cytokine receptor subunits. Proc Natl Acad Sci USA 1996; 93: 14002.